![Matthew E. Colpoys](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew E. Colpoys
Director/Board Member at
NEOS AB
Profile
Matthew E.
Colpoys is the founder of Tactiva Therapeutics LLC.
He is currently an Independent Director at NeoDynamics AB, Chief Operating Officer at Efferent Labs, Inc., and President at Galileo Consulting, Inc. Previously, he was the President & Chief Executive Officer at Woodbrook Group Holdings, Inc. from 2008 to 2009.
He received his undergraduate degree from Canisius College.
Matthew E. Colpoys active positions
| Companies | Position | Start |
|---|---|---|
| NEOS AB | Director/Board Member | 2020-12-31 |
Efferent Labs, Inc.
 Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Chief Operating Officer | - |
Galileo Consulting, Inc. | President | - |
Former positions of Matthew E. Colpoys
| Companies | Position | End |
|---|---|---|
| WOODBROOK GROUP HOLDINGS INC. | President | 2009-01-06 |
Tactiva Therapeutics LLC
 Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Chief Executive Officer | - |
Training of Matthew E. Colpoys
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Canisius College
 Canisius College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Woodbrook Group Holdings, Inc.
 Woodbrook Group Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
NeoDynamics AB
 NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
Efferent Labs, Inc.
Efferent Labs, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotechnology company which focuses on implantable biosensors for life sciences | Health Technology |
Tactiva Therapeutics LLC
Tactiva Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops adoptive cell therapies for cancer treatment | Health Technology |
Galileo Consulting, Inc. |
- Stock Market
- Insiders
- Matthew E. Colpoys
